Sanofi wrapped up a case involving arthritis injection Hyalgan. Amgen's $762 million marketing settlement has grabbed the biggest headlines, but Sanofi ($SNY) also ...

FLORHAM PARK, N.J.--(BUSINESS WIRE)--Fidia Farmaceutici S.p.A., a world leader in the research, development and manufacturing of hyaluronic acid-based products and its wholly owned subsidiary, Fidia ...

Dec 19 (Reuters) - French drugmaker Sanofi has agreed to pay $109 million to settle charges that it violated the False Claims Act by providing free drugs as a form of kickbacks to physicians, the U.S.

Senior woman suffering from pain in knees at home. Holding her knee and massaging with hands, feeling exhausted, sitting on sofa in living room. Close-up. Medications and pills on table Fidia Pharma ...

Sanofi is the latest pharmaceutical company to fall foul of the US Department of Justice and has reached a settlement over its promotion of the knee injection for arthritis product Hyalgan. Sanofi is ...